# CHA2DS2-VASc Score Calculator

Calculate CHA2DS2-VASc score for atrial fibrillation stroke risk. Get annual stroke risk estimate and anticoagulation recommendations based on current guidelines.

## What this calculates

The CHA2DS2-VASc score estimates the annual risk of stroke in patients with non-valvular atrial fibrillation (AF). It is the standard tool used worldwide to determine whether a patient with AF should be started on blood thinners to prevent stroke.

## Inputs

- **Congestive Heart Failure** — History of CHF or objective evidence of LV dysfunction
- **Hypertension** — Resting BP > 140/90 on at least 2 occasions or current antihypertensive treatment
- **Age** (years) — min 18, max 120
- **Diabetes Mellitus** — Fasting glucose > 125 mg/dL or treatment with oral hypoglycemic/insulin
- **Prior Stroke/TIA/Thromboembolism** — History of stroke, transient ischemic attack, or systemic embolism
- **Vascular Disease** — Prior MI, peripheral artery disease, or aortic plaque
- **Sex Category**

## Outputs

- **CHA2DS2-VASc Score** — Total score (0-9)
- **Annual Stroke Risk** — formatted as text — Estimated annual risk of stroke or systemic embolism
- **Anticoagulation Guidance** — formatted as text — General recommendation based on current guidelines

## Details

The CHA2DS2-VASc score assigns points for each risk factor:

- **C** - Congestive Heart Failure (1 point)
- **H** - Hypertension (1 point)
- **A2** - Age 75 or older (2 points)
- **D** - Diabetes Mellitus (1 point)
- **S2** - Prior Stroke, TIA, or thromboembolism (2 points)
- **V** - Vascular disease (1 point)
- **A** - Age 65-74 (1 point)
- **Sc** - Sex category: female (1 point)

The maximum score is 9 points. Higher scores mean higher annual stroke risk and a stronger recommendation for anticoagulation therapy.

**Key guideline recommendations (AHA/ACC/ESC):**

- **Score 0 (males) or 1 (females with only the sex point):** No anticoagulation needed. The stroke risk is very low.
- **Score 1 (males) or 2 (females):** Consider anticoagulation. This is a shared decision between patient and physician.
- **Score 2+ (males) or 3+ (females):** Anticoagulation is recommended. Direct oral anticoagulants (DOACs) are preferred over warfarin for most patients.

The female sex category point is handled differently because being female alone (without other risk factors) does not significantly increase stroke risk. It only adds meaningful risk when combined with at least one other clinical factor.

Note on bleeding risk: The HAS-BLED score is often used alongside CHA2DS2-VASc to assess bleeding risk with anticoagulation. However, a high bleeding risk score generally does not override the need for anticoagulation when stroke risk is high. Instead, it flags patients who need closer monitoring and modifiable bleeding risk factor management.

**Disclaimer:** This calculator is for educational purposes only. Anticoagulation decisions should always be made in consultation with a physician.

## Frequently Asked Questions

**Q: What is a CHA2DS2-VASc score of 0?**

A: A score of 0 in a male patient means the annual stroke risk is very low (approximately 0%) and no anticoagulation therapy is recommended. For a female patient, a score of 1 (from the sex category point alone) is treated the same as 0 because the female sex point without other risk factors does not meaningfully increase stroke risk.

**Q: Why does female sex get a point?**

A: Large studies have shown that female sex is an independent stroke risk modifier in atrial fibrillation, particularly when combined with other risk factors. Women with AF have a higher relative risk of stroke than men, especially after age 65. However, female sex alone (without any other risk factors) is not considered sufficient to warrant anticoagulation, which is why the guidelines treat score 1 in females differently from score 1 in males.

**Q: DOACs vs warfarin: which is better for AF?**

A: For most patients with non-valvular AF, direct oral anticoagulants (DOACs) like apixaban, rivarelbaan, edoxaban, and dabigatran are preferred over warfarin. DOACs have been shown in large trials to be at least as effective as warfarin for stroke prevention with a lower risk of intracranial bleeding. They also do not require regular blood monitoring (INR checks). Warfarin is still preferred for patients with mechanical heart valves or moderate-to-severe mitral stenosis.

**Q: Should I stop anticoagulation if my bleeding risk is high?**

A: Generally no. A high HAS-BLED score does not mean you should stop or avoid anticoagulation. The net clinical benefit of anticoagulation (strokes prevented minus bleeds caused) favors treatment at almost all CHA2DS2-VASc scores of 2 or higher, even with elevated bleeding risk. A high bleeding score should instead prompt your doctor to address modifiable bleeding risk factors (uncontrolled blood pressure, concomitant antiplatelet drugs, alcohol use) and monitor you more closely.

---

Source: https://vastcalc.com/calculators/health/cha2ds2-vasc
Category: Health & Fitness
Last updated: 2026-04-08